Acarix A/S Cash Flow Conversion Efficiency

Latest as of June 2026: -0.270x

Acarix A/S cash flow conversion efficiency. Based on the latest financial reports, Acarix A/S (ACARIX) has a cash flow conversion efficiency ratio of -0.270x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.83 Million ≈ $-1.27 Million USD) by net assets (Skr43.78 Million ≈ $4.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Acarix A/S (2014–2025)

Cash flow conversion efficiency of Acarix A/S from 2014 to 2025. This chart illustrates how Acarix A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Acarix A/S stock quote for real-time trading data and today's change.

Acarix A/S Cash Flow Conversion Ratio Explained

Acarix A/S cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Acarix A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Acarix A/S ranked by their cash flow conversion efficiency. Also see ACARIX company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Culico Metals Inc. V:CLCO	-0.044x
Killi Resources Ltd AU:KLI	-0.250x
Broadpeak SA PA:ALBPK	0.386x
Sustainable Power & Infrastructure Split Corp TO:PWI	0.089x
Radiant Innovation TWO:3373	0.014x
BIONXT SOLUTIONS INC. F:BXT	0.080x
Longeveron LLC NASDAQ:LGVN	-0.384x
CHINA NEW ENERGY LS-00025 F:9H5	N/A

Annual Cash Flow Conversion Efficiency for Acarix A/S (2014–2025)

The table below shows the annual cash flow conversion efficiency of Acarix A/S from 2014 to 2025. Review Acarix A/S free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr38.17 Million ≈ $4.11 Million	Skr-48.38 Million ≈ $-5.21 Million	-1.268x	-51.52%
2024-12-31	Skr75.70 Million ≈ $8.15 Million	Skr-63.33 Million ≈ $-6.81 Million	-0.837x	+46.65%
2023-12-31	Skr51.88 Million ≈ $5.58 Million	Skr-81.37 Million ≈ $-8.76 Million	-1.568x	-8.55%
2022-12-31	Skr51.83 Million ≈ $5.58 Million	Skr-74.87 Million ≈ $-8.06 Million	-1.445x	-202.56%
2021-12-31	Skr100.54 Million ≈ $10.82 Million	Skr-48.01 Million ≈ $-5.17 Million	-0.477x	-6.90%
2020-12-31	Skr82.14 Million ≈ $8.84 Million	Skr-36.69 Million ≈ $-3.95 Million	-0.447x	+23.17%
2019-12-31	Skr76.60 Million ≈ $8.24 Million	Skr-44.53 Million ≈ $-4.79 Million	-0.581x	-32.32%
2018-12-31	Skr87.88 Million ≈ $9.46 Million	Skr-38.61 Million ≈ $-4.15 Million	-0.439x	-39.74%
2017-12-31	Skr128.94 Million ≈ $13.88 Million	Skr-40.54 Million ≈ $-4.36 Million	-0.314x	-439.92%
2016-12-31	Skr155.52 Million ≈ $16.74 Million	Skr-9.06 Million ≈ $-974.57K	-0.058x	+91.81%
2015-12-31	Skr12.14 Million ≈ $1.31 Million	Skr-8.63 Million ≈ $-928.83K	-0.711x	+48.48%
2014-12-31	Skr15.12 Million ≈ $1.63 Million	Skr-20.87 Million ≈ $-2.25 Million	-1.380x	--

About Acarix A/S

ST:ACARIX Sweden Medical Devices

Market Cap

$23.63 Million

Skr219.57 Million SEK

Market Cap Rank

#24412 Global

#476 in Sweden

Share Price

Skr0.18

Change (1 day)

-1.67%

52-Week Range

Skr0.18 - Skr0.34

All Time High

Skr20.62